ReferenceID 3978

Scrophularia buergeriana attenuates allergic inflammation by reducing NF-κB activation

Phytomedicine

BACKGROUND: Scrophularia buergeriana Miq. (Scrophulariaceae) (SB) has been used as an oriental medicine for the treatment of inflammatory diseases, such as neuritis and pharyngolaryngitis. PURPOSE: We explored the therap

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Herb: 1Reference: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final reference record.

Reference Id
3978
Evidence Id
20568
Core Evidence Id
20568
Source Reference Id
1229
Herb2 Reference Id
HBREF002026
Subject Paper Key
HERB000410_31901567
Pubmed Id
31901567
Doi
10.1016/j.phymed.2019.153159
Paper Title
Scrophularia buergeriana attenuates allergic inflammation by reducing NF-κB activation
Paper Abstract
BACKGROUND: Scrophularia buergeriana Miq. (Scrophulariaceae) (SB) has been used as an oriental medicine for the treatment of inflammatory diseases, such as neuritis and pharyngolaryngitis. PURPOSE: We explored the therapeutic effects of S. buergeriana ethanol extract (SBE) on airway inflammation in ovalbumin (OVA)-induced asthmatic mice and lipopolysaccharide (LPS)-stimulated RAW264.7 cells. METHODS: Mice were intraperitoneally injected with OVA on days 0 and 14 to elevate the immune response. On days 21 to 23, the mice were challenged with OVA solution and SBE (20 and 40 mg/kg) was administered daily by oral gavage from days 18 to 23. RAW264.7 cells were pretreated with SBE 1 h before LPS stimulation. RESULTS: SBE administration effectively suppressed inflammatory cell infiltration, the expression of interleukin (IL)-5, IL-13, and IL-17, immunoglobulin E, and airway hyperresponsiveness in an OVA-induced allergic asthma model. A reduction in histological alterations, including airway inflammation and mucus hypersecretion, was observed. These effects of SBE were accompanied by a decrease in matrix metalloproteinase-9 (MMP-9) expression and nuclear factor kappa B (NF-kappaB) phosphorylation. These responses were observed in LPS-stimulated RAW264.7 cells. SBE treatment reduced the mRNA expression of tumor necrosis factor (TNF)-alpha, IL-6, and MMP-9, and NF-kappaB phosphorylation, in LPS-stimulated RAW264.7 cells. CONCLUSION: Our results indicated that SBE effectively attenuated airway inflammation in an OVA-induced allergic asthma model. These properties of SBE were thought to be involved in the suppression of NF-kappaB phosphorylation, suggesting that the material has the potential to regulate the development of allergic asthma.
Journal
Phytomedicine
Publish Year
2020
Experiment Subject
mouse; lipopolysaccharide (lps)-stimulated raw264.7 cells; lps-stimulated raw264.7 cells; raw264.7 cells
Experiment Type
Animal Experiment
Phenotype Related
Airway Hyperresponsiveness; Inflammatory Diseases; Ova-induced Allergic Asthma; Tumor; Attenuated Airway Inflammation; Neuritis; Pharyngolaryngitis; Airway Inflammation; Mucus Hypersecretion; Allergic Asthma
Paper Title Cn
Paper Title En
Scrophularia buergeriana attenuates allergic inflammation by reducing NF-κB activation
Bilingual Status
semi_complete